All News

Investigators are set to begin testing sulfasalazine and auronofin, which are FDA-approved to treat rheumatoid arthritis, in cancer cell models.

Research over the past decade has shown that PV can be associated with a reduction in survival compared with age- and gender-matched population controls.

Due to the high-touch, high-risk nature of specialty medications, specialty pharmacies must incorporate robust programs to ensure proper medication usage and minimize the potential for error or adverse events.

The study authors suggest that the biggest boost in risk reduction would stem from communication efforts aimed at raising awareness of COVID-19 risks among US adults under 40 years of age.

According to findings from a December 2020 national survey, more US adults reported receiving or planning to receive an influenza vaccination during the 2020-2021 flu season than ever before.

Previous studies have explored the benefits of vitamins D and C, as well as minerals such as zinc and magnesium, in fortifying the immune response against COVID-19.

The FDA has approved a supplemental new drug application for lorlatinib (Lorbrena) to expand the indication to include the frontline treatment of patients with ALK-positive non–small cell lung cancer.

Pharmacy Times® interviewed Sarah Browne, MD, senior director of vaccine development at Altimmune, on the commencement of a phase 1 clinical trial of a single-dose, intranasal COVID-19 vaccine.

In Vienna in the 1770s, a young physician named Franz Friedrich Anton Mesmer happened to meet a Jesuit priest named Maximilian Hell who was conducting medical experiments on patients with rheumatism.

Third party payers have concluded that the fee-for-service system is no longer financially viable and that a new approach is necessary.

Many rural areas identify with many barriers in their community, such as transportation, technology access, human factors, and the design of the health care model.

Recent data have shown alarmingly low rates of human papillomavirus (HPV) vaccine completion among children between 10 and 13 years of age.

Cognitive impairment includes memory and thinking problems that affect concentration, decision making and learning new things, which increases as people grow older.

The study found patients who used mHealth applications had better health outcomes and were able to regulate their health behavior more effectively than patients who did not use these apps, in addition to fewer hospital visits and lower medical costs.

Social media has developed into a powerful and versatile device that can inform and reach a multitude of persons almost instantaneously.

The first vaccine dose alone offered strong protection against COVID-19, with efficacy that did not decline over the 3 months between doses.

Training gives pharmacy staff the tools needed to initiate uncomfortable conversations about mental health and substance use issues.

Paul Ament, PharmD, reviews the guidelines for the treatment of VTE.

ACIP issued an interim recommendation to the Janssen COVID-19 vaccine for use in individuals aged ≥18 years for the prevention of COVID-19.

President Joseph Biden announced a partnership between Merck and Johnson & Johnson, in which 2 of Merck’s facilities will begin producing the Johnson & Johnson COVID-19 vaccine.

The availability of both intravenous and subcutaneous routes of immunoglobulin has made personalization of treatment more important than ever.